Procter & Gamble officer Andre Schulten filed a Form 144 notice on November 2, 2026, disclosing a proposed sale of 64,301 shares of Procter & Gamble common stock with an approximate sale date of November 3, 2026.

Key Highlights

  • Proposed shares: 64,301 shares of Procter & Gamble common stock are proposed to be sold.
  • Aggregate market value: The filing states an aggregate market value of $10,493,601.70, based on the average of the high and low price on October 30, 2026.
  • Acquisition method: The shares are to be acquired via two stock option exercises from The Procter & Gamble Company: 33,624 shares and 30,677 shares, both on November 3, 2026.
  • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza, 38th Floor, New York, NY 10004, is named as broker.
  • Prior sales in past 3 months: Schulten sold 3,914 shares on October 5, 2026 for gross proceeds of $568,860.76, and 5,402 shares on August 20, 2026 for gross proceeds of $776,753.58.
  • Shares outstanding: The filing reports 2,317,783,143 shares of common stock outstanding.

Schulten Stock Option Exercise and Proposed Sale Details

According to the filing, Andre Schulten, identified as an officer of Procter & Gamble Co (NYSE:PG), submitted a Form 144 notice dated November 2, 2026, covering a proposed sale of 64,301 shares of common stock. The filing attributes the acquisition of these shares to two separate stock option exercises from The Procter & Gamble Company, one for 33,624 shares and one for 30,677 shares, both with an acquisition date of November 3, 2026. Payment for both transactions is described as cash, and the filing notes that "Acquisition and payment dates for stock option exercise will be the same."

The filing states the aggregate market value of the proposed sale is $10,493,601.70, calculated using the average of the high and low price on October 30, 2026. The notice was signed by Aaron B. Shepherd as attorney-in-fact for Andre Schulten. The filing discloses that in the preceding three months, Schulten sold 3,914 shares on October 5, 2026 for gross proceeds of $568,860.76, and 5,402 shares on August 20, 2026 for gross proceeds of $776,753.58, both of Procter & Gamble common stock.

The Form 144 was filed with the SEC by filer CIK 0001844763 in connection with a proposed sale on the NYSE. Procter & Gamble Co is located at One Procter & Gamble Plaza, Cincinnati, Ohio 45202, and carries SEC file number 001-00434. Total shares of common stock outstanding are reported as 2,317,783,143.

What Was Disclosed

A Procter & Gamble officer, Andre Schulten, filed a Form 144 on November 2, 2026, proposing to sell 64,301 shares via stock option exercises on November 3, 2026, with an aggregate market value of $10,493,601.70, through Morgan Stanley Smith Barney LLC.